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ILLUSTRATIVE CASE
The parents of a 10-year-old patient 
whom you recently diagnosed with 
asthma want to do everything they can to 
reduce his asthma symptoms. They are 
considering buying hypoallergenic mattress 
covers and an expensive air fi ltration 
system to decrease the levels of dust mite 
allergens in their home and want to know if 
you think that will help their son. What do 
you tell them?
 
We want to do everything we can to help our patients control their asthma symp-
toms, but when it comes to house-
hold dust mite control measures, 
this extensive Cochrane review confi rms 
that interventions like mattress covers 
and air fi ltration don’t work, despite re-
cent reviews and guidelines recommend-
ing them.
Dust mites (Dermatophagoides pter-
onyssinus) are one of the most common 
allergens that provoke asthma symptoms 
in children and adults.2 Dust mites live in 
warm, humid places and feed on human 
skin scales. The areas with the highest lev-
els of household infestation are carpets, 
mattresses, pillows, drapes, upholstered 
furniture, and clothing. 
❚  Guidelines still encourage 
mattress cover use
The National Asthma Education and Pre-
vention Program (NAEPP) 2007 guide-
lines recommend using allergen-imper-
meable mattress and pillow covers and 
washing sheets and blankets in hot wa-
ter.  They also recommend “considering” 
reducing indoor humidity, removing 
bedroom carpets, and washing stuffed 
toys weekly.  The NAEPP Expert Panel 
cites many studies to support these rec-
ommendations.3  
The National Environmental Educa-
tion and Training Foundation (NEETF) 
Stop recommending dust mite 
control measures to your 
asthma patients. Neither 
chemical nor physical 
reduction measures are 
effective in improving peak 
fl ow, symptoms of asthma, 
or medication usage.1
Strength of recommendation 
B: Based on a meta-analysis of 54 fair quality randomized 
trials in patients with mite-sensitive asthma
Gotzsche PC, Johansen HK. House dust mite 
control measures for asthma. Cochrane Database 
Syst Rev. 2008;(2):CD001187.
Practice changer 
Dust mite control measures 
don’t help asthma patients 
Forget about mattress covers and air fi ltration systems. 
They don’t work, despite what the guidelines say 
To what extent do 
you encourage or 
discourage patients 
from using dust mite 
control measures?
❑  Encourage most 
patients to use them
❑  Encourage selected 
patients to use them
❑  Neither encourage nor 
discourage patients
❑  Discourage patients 
from using them
 Go to www.jfponline.com
and take our Instant Poll!
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2005 guidelines recommend additional 
measures to reduce dust mite expo-
sure including vacuuming using a high-
effi ciency particulate air (HEPA) fi lter, 
removing draperies, and considering us-
ing a portable air cleaner with a HEPA 
fi lter.4
STUDY SUMMARY
❚  54 trials, but no support
for dust mite measures
This Cochrane systematic review includ-
ed 54 randomized trials that assessed the 
effects of physical and/or chemical in-
terventions to reduce exposure to house 
dust mite antigens in the homes of pa-
tients with mite-sensitive asthma. These 
studies included a total of 3002 pediatric 
and adult asthma patients (9 - 628 pa-
tients analyzed per trial) with mite sensi-
tization confi rmed by skin testing or IgE 
serum assays.  
Thirty-six studies tested physical in-
terventions, including mattress covers, 
vacuum cleaning, heating, ventilation, 
freezing, washing, air fi ltration, and ion-
izers.  Ten used chemical interventions 
to kill dust mites; 8 used a combination 
of physical and chemical methods. Con-
trol groups received either placebo or no 
treatment.
Outcomes studied. The authors ex-
tracted data for the following outcomes: 
subjective well-being, asthma symptom 
scores, use of medication, days of sick 
leave from school or work, number of 
unscheduled visits to a physician or hos-
pital, forced expiratory volume in 1 sec-
ond (FEV1), peak expiratory fl ow rate 
(PEFR), and provocative concentration 
that causes a 20% fall in FEV1 (PC20). 
Length of the intervention and follow-up 
ranged from 2 weeks to 2 years.
Quality of studies. According to mod-
ern standards for randomized trials, the 
quality of many of the 54 studies was not 
optimal, especially in the descriptions of 
randomization and the reporting of out-
comes. The method of randomization and 
concealment of allocation was rarely de-
scribed. Eleven trial reports did not con-
tain any usable data for the meta-analysis 
because of the way data were reported, 
and there was signifi cant potential for re-
porting bias in favor of a treatment effect 
in the studies included. Mite reduction 
was successful in 17 trials, unsuccessful 
in 24 trials, and not reported in 13 trials. 
Interventions didn’t help. There were 
no differences between the intervention 
and control groups for any of the out-
comes. The percentage of patients who 
improved after the experimental inter-
ventions was not signifi cantly different 
from the percentage of patients in the 
control groups (relative risk [RR]=1.01; 
95% confi dence interval [CI], 0.80-1.27; 
data based on 7 trials). There was no dif-
ference in medication usage (data from 
10 trials), FEV1 (data from 14 trials), 
morning PEFR (data from 23 trials), 
or PC 20 (data from 14 trials) between 
the intervention and control groups 
(TABLE).1
WHAT’S NEW?
❚  Nothing is new, yet this 
will be “news” to many
This Cochrane review includes 5 addi-
tional trials that have been conducted 
since the last Cochrane review of this 
topic in 2004. However, the 2004 re-
view reported the same conclusion—that 
interventions to reduce house dust mite 
exposure in asthma patients are ineffec-
tive—as did 3 other Cochrane reviews on 
the same topic beginning in 1998.5-8
 So why are the guidelines out of 
step? Schmidt and Gøtzsche (one of the 
authors of the Cochrane review) conduct-
ed a systematic review of narrative review 
articles in 2005 to answer this question. 
They found 70 review articles, 90% of 
which recommended physical methods 
to reduce exposure to house dust mites. 
They discovered that although these re-
view articles included references to sup-
port their recommendations of dust mite 
control measures, the reviews showed 
signifi cant bias in favor of positive studies 
PURLs methodology
This study was selected and 
evaluated using FPIN’s Priority 
Updates from the Research 
Literature (PURL) Surveillance 
System methodology. The 
criteria and ﬁ ndings leading to 
the selection of this study as 
a PURL can be accessed at 
www.jfponline.com/purls. 
There was no 
difference in 
medication usage, 
FEV1, or morning 
peak fl ow between 
patients who used 
mattress covers 
and air fi ltration 
systems and those 
who did not 
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and highlighted the results of low-quality 
studies, including non-randomized stud-
ies that had been excluded from the Co-
chrane reviews.9  
CAVEATS
❚  Duration of studies 
not long enough?
We know that extreme measures to re-
duce exposure to dust mite allergen, such 
as relocating to a high altitude or pro-
longed hospitalization, can reduce asth-
ma symptoms,10,11 but these are clearly 
not practical solutions for most patients 
with dust mite-sensitive asthma. When 
it comes to this Cochrane review, some 
might argue that many of the interven-
tions included were not of suffi cient du-
ration and did not suffi ciently reduce the 
level of house mite allergen to improve 
asthma symptoms.  
However, the subgroups of trials 
with long treatment duration (1-2 years) 
and successful mite reduction (deter-
mined by different methods, including 
mite counts and measured antigen levels 
in dust samples) also failed to show a sig-
nifi cant difference between intervention 
and control groups.1 
Tweak the approach? Most dust mite- 
sensitive asthma patients are sensitive to 
other allergens, so perhaps multifaceted 
interventions that target multiple aller-
gens would be more effective.12 But until 
these potential interventions are support-
ed by stronger evidence, we should not 
recommend them to our patients.
CHALLENGES TO IMPLEMENTATION
❚  Swimming against 
the tide is never easy
Although the evidence to date indicates 
that interventions to reduce home dust 
mite exposure are ineffective, there are 
hundreds of products—including mat-
tress and pillow covers ($10-$100), ioniz-
ers ($100-$200), and air fi ltration systems 
($500-$800)—that are being marketed 
to patients with asthma. In addition, 
patient education handouts from sourc-
es such as the American Academy of 
Family Physicians, the American Acad-
emy of Pediatrics, and UpToDate recom-
mend implementing dust mite control 
measures to reduce dust mite allergen 
exposure.13-15 
We need to start educating our 
asthma patients properly so they can 
spend their time, energy, and money on 
interventions, such as medications, that 
work—and not on interventions that 
make no difference. ■
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